Resmed Inc. sell Wolfe Research
Start price
18.09.24
/
50%
€218.20
Target price
18.09.25
€161.78
Performance (%)
-0.55%
Price
26.09.24
€217.00
Summary
This prediction is currently active. Since the start of the prediction for Resmed Inc. the price has only changed by -0.55%. This prediction currently runs until 18.09.25. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Resmed Inc. | 1.027% |
iShares Core DAX® | 0.936% |
iShares Nasdaq 100 | 3.064% |
iShares Nikkei 225® | 1.898% |
iShares S&P 500 | 1.653% |
Comments by Wolfe_Research for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its "underperform" rating re-affirmed by analysts at Wolfe Research. They now have a $180.00 price target on the stock.
Ratings data for RMD provided by MarketBeat